Company Information
CIN
Status
Date of Incorporation
02 December 2003
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
21 October 2023
Paid Up Capital
384,615,380
Authorised Capital
4,100,000,000
Directors
Anil Khubchandani
Director/Designated Partner
over 2 years ago
over 2 years ago
Srinivasareddy Desireddy
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Pagadala Baskarannarayanan
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Sunil Goutham Baffna
Director/Designated Partner
about 3 years ago
about 3 years ago
Durga Prasad Reddy Avula
Director/Designated Partner
about 3 years ago
about 3 years ago
Ashwin Savio Trinidad
Director/Designated Partner
about 3 years ago
about 3 years ago
Prakash Amrut Mody
Director/Designated Partner
over 6 years ago
over 6 years ago
Desireddy Triveni Reddy
Director/Designated Partner
almost 9 years ago
almost 9 years ago
Venkata Srinivasarao Velivela
Director
almost 16 years ago
almost 16 years ago
Past Directors
Sundar Raj Ananthakrishnan
Additional Director
about 3 years ago
about 3 years ago
Prabhat Kumar Kulshershta
Director
almost 20 years ago
almost 20 years ago
Patents
The present invention relates to an improved process for the preparation of2-(3-fluoro-4-(methyi-carbamoyI)phenyi-amino)-2-methyI-propionic acid ethyl ester comprising, 2-fluoro-4-nitrobenzoic acid (HI) is reacted with methanol in presence of acid to produce methyl 2-fluoro-4-nitrobenzoate of formula (X); which is r...
The present invention provides a simple, environmental friendly process for the preparation of crystalline form of Linezolid. The present invention also provides pure crystalline form of Linezolid in good yield.
The present invention relates to an improved process for preparing the diamine intermediate, ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate, compound of formula (I), used in preparation of Dabigatran. The present invention relates to a simple, cost-effective pro cess for preparing compound of ...
The present invention is directed towards novel process for the preparation of Rivaroxaban. The process is cost effective and industrially viable.
The present invention provides a novel process for the preparation of tert-butyl 2-((2R, 4S)-4-formyl-l,5-dioxaspiro[5.5]undecan-2-yl)acetate of formula (I). The present invention further relates to a process for the preparation of Rosuvastatin calcium by using the formula (I)
ABSTRACT:
The present invention relates to a novel processes for preparing Rosuvastatin Calcium.
ABSTRACT
TITLE: "AN IMPROVED PROCESSES FOR PREPARING LINEZOLID"
The present invention provides simple, environmental friendly improved process for the preparation of Linezolid. The present invention also provides an alternate improved process for preparing Linezolid with good yield.
ABSTRACT:
The present invention provides simple, environmental friendly improved processes for the preparation of Linezolid. The present invention also provides an alternate improved process for preparing Linezolid in good yield.
ABSTRACT
TITLE: “PROCESS FOR THE PREPARATION OF TEDIZOLID PHOSPHATE”
The present invention relates to a process for the preparation of Tedizolid Phosphate. The present invention is also provides industrial applicable, commercially and eco-friendly viable process for the preparation of Tedizolid Phosphate.
...
The present invention relates to crystalline form of Ozenoxacin and its process for the preparation.
PROCESS FOR THE PREPARATION OF FEBUXOSTAT
The present invention relates to an improved, commercially viable and industrially advantageous process for the preparation of Febuxostat.
ABSTRACT
TITLE: “PROCESS FOR THE PREPARATION OF DIMETHINDENE MALEATE”
The present invention relates to a process for the preparation of Dimethindene maleate formula (I) by employing a key intermediate of 2-(2-(dimethylamino) ethyl-2, 3-dihydroinden-1-one acid salt formula (IIIa). The present invention also relates...
The present invention relates to amorphous form of Ozenoxacin. The present invention is also relates to improved, commercially viable and industrially advantageous process for the preparation of Ozenoxacin.
The present invention relates to improved, commercially viable and industrially advantageous process for the preparation of crystalline form III of Linezolid.
The present invention relates to a process for the preparation of (±)-Ritalinic acid hydrochloride with cost effective and industrial applicable by employing a novel step.
The present invention relates to improved process for the preparation of (S)-Dapoxetine or an acid addition salt thereof and also provides an enantiomerically pure form of Dapoxetine hydrochloride
The present invention relates to a process for the preparation of Fenticonazole nitrate of Formula (I) with commercially viable and industrial applicable process.
The present invention relates to an improved process for the preparation of Phenyramidol hydrochloride of Formula (I) with commercially viable and industrial applicable process.
The present invention provides a novel process for the preparation of 1-benzofuran-6-carboxylic acid of formula (II) by employing novel compound of [2-formyl-5-(methoxycarbonyl) phenoxy] acetic acid of formula (VI).
The present invention provides a novel process for the preparation of methyl-1-benzofuran-6-carboxylate of formula (II).
The present invention relates to an improved process for the preparation of Eberconazole nitrate by using Carbonyldiimidazole. The present invention is also relates to simple and cost effective process for the preparation of Eberconazole nitrate.
The present invention relates to a process for the preparation of N-(5-Chloro-2-nitrophenyl) phenyl amine, compound of formula (I) with high purity and good yield, which is a key intermediate for the preparation of Clobazam.
ABSTRACT
TITLE: “NOVEL PROCESS FOR THE PREPARATION OF (+)-CIBENZOLINE SUCCINATE”.
The present invention relates to a crystalline form of (+)-Cibenzoline succinate. The present invention is also related to a process for the preparation of (+)-Cibenzoline succinate with chiral purity greater than 99.9%. The present...
ABSTRACT
TITLE: “NOVEL PROCESS FOR THE PREPARATION OF (-)-CIBENZOLINE
SUCCINATE”.
The present invention relates to a crystalline form of (-)-Cibenzoline succinate. The present invention is also related to a process for the preparation of (-)-Cibenzoline succinate with chiral purity greater than 99.9%. The presen...
The present invention provides a process for the preparation sodium (s)-4-oxo-4, 6, 7, 8-tetrahydropyrrolo [1, 2-a] pyridine-6-carboxylate of formula (II). The present invention is also provides commercially, synthetically by industrially applicable method to ensure the availability with high purity.
...
ABSTRACT
TITLE: CRYSTALLINE FORM OF RIFAXIMIN
The present invention relates to a novel crystalline form of rifaximin and process for its preparation thereof.
ABSTRACT
TITLE: PROCESS FOR THE PREPARATION OF LINEZOLID FORM III
The present invention relates to improved, commercially viable and industrially applicable process for the preparation of crystalline form III of Linezolid.
The present invention provides a process for the preparation E-isomer of Luliconazole (I) with substantially free of Z-isomer and unwanted salts.
The present invention relates to the novel compound of Ubiquinol di-Tocopherol succinate ester (I). The present invention further provides an improved, commercially viable and industrially advantageous process for the preparation of Ubiquinol di-Tocopherol succinate ester (I).
Abstract
Title: PROCESS FOR THE PREPARATION OF PURE 3-n-BUTYLPHTHALIDE
The present invention relates to an improved, commercially viable and industrially advantageous process for the preparation of 3-n-Butylphthalide. The present invention further provides a process for the preparation of highly pure 3-n-But...
ABSTRACT
Title: “NOVEL SYNTHESIS OF FAVIPIRAVIR AND ITS INTERMEDIATE”
The present invention relates to a novel process for the preparation of Favipiravir intermediate. The present invention is also relates to an improved, commercially viable and industrially advantageous process for the preparation of highly p...
ABSTRACT
TITLE: “PURIFICATION PROCESS OF FAVIPIRAVIR”
The present invention relates to purification process of Favipiravir. The present invention further relates to an improved, commercially viable, industrially advantageous, and environmental friendly process for the preparation of Favipiravir with highly p...
The present invention relates to an improved process for the preparation of 4-Phenylmorpholin-3-one with commercially viable and industrially applicable process in terms of good yield and purity.
ABSTRACT
TITLE: “PROCESS FOR THE PREPARATION OF (3R,4R)-(1-BENZYL-4-METHYLPIPERIDIN-3-YL)-METHYLAMINE”
The present invention relates to a process for preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine (1) by employing novel compound of formula (4) and (5). The compound of formula (1) is a key...
ABSTRACT
TITLE: “PROCESS FOR THE PREPARATION OF BILASTINE”
The present invention relates to an improved, commercially viable, industrially advantageous and cost effective process for the preparation of Bilastine with good yield and purity
ABSTRACT
“SYNTHESIS OF FAVIPIRAVIR”
The present invention relates to a process for the preparation of Favipiravir. The present invention is also relates to an improved and commercially viable process of Favipiravir by using 6-fluoro-3-hydroxypyrazine-2-carbonitrile ammonia salt.
ABSTRACT
Title: “ONE POT SYNTHESIS OF FAVIPIRAVIR”
The present invention relates to a one pot process for the preparation of Favipiravir. The present invention is also relates to an improved, commercially viable, industrially advantageous, easier to handle and environmental friendly process for the preparation...
ABSTRACT
Title: “PROCESS FOR THE PREPARATION OF FAVIPIRAVIR”
The present invention relates to a process for the preparation of Favipiravir. The present invention is also relates to an improved, commercially viable, industrially advantageous, easier to handle and environmental friendly process for the preparati...
ABSTRACT
“IMPROVED PROCESS FOR MOLNUPIRAVIR”
The present invention relates to a process for the preparation of Molnupiravir. The present invention also relates to an improved and commercially viable process for preparation of Molnupiravir with high yield and purity.
TITLE: “AN IMPROVEDPROCESS FOR THE PREPARATION OF SUTEZOLID”
The present invention relates to an improved, commercially viable and industrially advantageous process for the preparation of Sutezolid and its intermediates
TITLE: “A NOVEL PROCESS FOR THE PREPARATION OF SUTEZOLID ”
A novel process for the preparation of Sutezolid and the present invention is also provides most economical and industrial applicable process.
The present invention relates to purification process of Obeticholic acid (I). The present invention further relates to crystalline forms of Obeticholic acid, which are useful to produce highly pure amorphous Obeticholic acid.
TITLE: “ONE POT PROCESS FOR THE PREPARATION OF DICYCLOHEXYL AMINE SALT OF 6-FLUORO-3-HYDROXY-2-PYRIDINE CARBONITRILE”
The present invention relates to one pot process for the preparation of dicyclohexylamine salt of 6-fluoro-3-hydroxy-2-pyridine carbonitrile commercially viable and industrially applicable pro...
TITLE: CRYSTALLINE FORM XI OF RIFAXIMIN
The present invention relates to a novel crystalline Form XI of Rifaximin and also relates to purification process of Rifaximin.
ABSTRACT
TITLE: “AN IMPROVED PROCESS FOR PREPARATION OF BEMPEDOIC ACID”
The present invention relates to an improved process for the preparation of Bempedoic acid (I), comprising hydrolyzing the compound of formula (4) with ionic liquid to obtain the compound of formula (5), which is converting to Bempedoic ac...
ABSTRACTTITLE: "A PROCESS FOR THE PREPARATION OF DABIGATRAN ETEXILATE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF"The present invention is relates to a process for the preparation of Dabigatran etexilate and pharmaceutically acceptable salts thereof. The present invention is also relates to a p...
ABSTRACT
Title: “IMPROVEED PROCESS FOR PREPARATION OF BEMPEDOIC ACID”
The present invention relates to an improved, commercially viable and industrially advantageous process for the preparation of Bempedoic acid (I) with good yield and high purity using dicyclohexylammonium 2,2,14,14-tetramethyl-8-oxo pentadec...
“Process For The Preparation Of 4 (4 Isopropoxybenzyl) 1 Isoppropyl 5 Methyl 1 H Pyrazol 3(2 H) One”
ABSTRACT
TITLE: “PROCESS FOR THE PREPARATION OF PROCESS FOR THE PREPARATION OF 4-(4-ISOPROPOXYBENZYL)-1-ISOPPROPYL-5-METHYL-1H-PYRAZOL-3(2H)-ONE”
The present invention relates to a process for the preparation of 4-(4-Isopropoxybenzyl)-1-isoppropyl-5-methyl-1H-pyrazol-3(2H)-one of formula (I).
...
TITLE: CRYSTALLINE FORM I OF CAMOSTAT MESILATE
The present invention relates to crystalline form I of Camostat mesilate. The present invention also relates to a purification process for preparing Camostat mesilate.
TITLE: PURIFICATION PROCESS OF STABLE FORM A LINAGLIPTIN
The present invention relates to improved, commercially viable and industrially applicable purification process of stable form A Linagliptin with high purity and yield.
ABSTRACT
TITLE: CRYSTALLINE FORM “P” OF BEMPEDOIC ACID
The present invention relates to crystalline form “P” of Bempedoic acid. The present invention also relates to a purification process for preparing crystalline form “P” of Bempedoic acid with high purity and yield.
TITLE: CRYSTALLINE FORM I OF BUCILLAMINE
The present invention relates to crystalline form I of Bucillamine. The present invention also relates to a purification process for preparing crystalline form I of Bucillamine.
ABSTRACT
TITLE: NOVEL CRYSTALLINE FORM OF MIDODRINE HYDROCHLORIDE
The present invention relates to purification process for Midodrine hydrochloride. And the present invention also relates to novel crystalline Form “OP” of Midodrine hydrochloride.
ABSTRACT
“IMPROVED PROCESS FOR DAPAGLIFLOZIN PROPANE DIOL MONOHYDRATE”
The present invention relates to an improved process for preparing (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol(2S)-1,2-propanediol, hydrate i.e, Dapagliflozin Propanediol monohydrate (I), simple, efficient m...
ABSTRACT
“PROCESS OF MOLNUPIRAVIR”
The present invention relates to a process for preparation of Molnupiravir (1) by employing novel compound of formula (2), (3) and (4). The present invention is also relates to an improved and commercially viable process of Molnupiravir with high yield and purity.
...
ABSTRACT
“SYNTHESIS OF BRIVARACETAM”
The present invention relates to a novel compound of (S)-2-((Z)-((R)-4-propyldihydrofuran-2(3H)-ylidene) amino) butanamide and an improved, commercially viable process for preparation of Brivaracetam using (S)-2-((Z)-((R)-4-propyldihydrofuran-2(3H)-ylidene) amino) butanamide....
ABSTRACT
“IMPROVED PROCESS FOR 2-DEOXY-D-GLUCOSE”
The present invention relates to commercially, industrial applicable and improved process for the preparation of 2-Deoxy-D-glucose (I). The present invention is also provides simple, efficient more economical and eco-friendly process.
...
ABSTRACT
“PROCESS FOR PREPARING ELAGOLIX”
The present invention relates to a process for the preparation of Elagolix sodium comprising isolating of solid crystalline Form-P of compound (V). The present invention also relates to a solid crystalline Form-P of compound of formula (V).
...
ABSTRACT
“IMPROVED PROCESS FOR TAFAMIDIS”
The present invention relates to a process for the preparation of Tafamidis. The present invention is also relating to an improved and commercially viable process of Tafamidis with high yield.
ABSTRACT
“IMPROVED PROCESS FOR THE PREPARATION OF ELAGOLIX”
The present invention relates to an improved process for the preparation of Elagolix sodium with simple, high purity and good yield.
ABSTRACT
TITLE: “PREPARATION OF SITAGLIPTIN PHOSPHATE MONOHYDRATE”
The present invention relates to a process for the preparation of Sitagliptin phosphate monohydrate (I) from the novel compound of (2Z)-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-[[(1R)-1-phenylethyl]amino]-4-(2...
ABSTRACT
Title: “A PROCESS FOR PREPARATION OF BEMPEDOIC ACID AND ITS INTERMEDIATES”
The present invention relates to an improved, commercially viable and industrially advantageous process for the preparation of Bempedoic acid (I) with good yield and high purity via dicyclohexylamine salt of Bempedoic acid (5). T...
ABSTRACT
“PROCESS FOR (R)-4-PROPYLDIHYDROFURAN-2(3H)-ONE”
The present invention relates to an improved process for the preparation of (R)-4-propyldihydrofuran-2 (3H)-one (I), which is a key intermediate for the preparation of Brivaracetam. The present invention is also relating to a commercially viable and co...
ABSTRACT
“IMPROVED PROCESS FOR TERIFLUNOMIDE”
The present invention relates to a process for the preparation of Teriflunomide. The present invention is also relating to an improved and commercially viable process of Teriflunomide with high yield and high purity.
ABSTRACT
“IMPROVED PROCESS FOR (R)-4-PROPYLDIHYDROFURAN-2(3H)-ONE”
The present invention relates to a process for the preparation of (R)-4-propyldihydrofuran-2 (3H)-one (I), which is a key intermediate for the preparation of Brivaracetam. The present invention is also relating to an improved and commercially vi...
ABSTRACT
“A PROCESS FOR THE PURIFICATION OF MOLNUPIRAVIR WITH SUBSTANTIALLY FREE FROM IMPURITIES”
The present invention provides an efficient process for the purification of Molnupiravir with substantially free from impurities such as Dimethyl dioxol impurity (I), Acetyl impurity (II) and N-Hydroxycytidine impur...
ABSTRACT
TITLE: “PROCESS FOR BEMPEDOIC ACID USING NOVEL INTERMEDIATES”
The present invention relates to process for the preparation of Bempedoic acid (I) and the present invention further relates to a novel intermediate compounds of formulae (3) and (4) are used in the preparation of Bempedoic acid (I).
...
ABSTRACT
“NOVEL PROCESS FOR THE PREPARATION OF FINERENONE”
The present invention relates to a novel process for the preparation of Finerenone from the compound of formulae (IV), (VI), (VII) and (VIII).
“IMPROVED PROCESS FOR THE PREPARATION OF FINERENONE”
The present invention provides an improved process for the preparation of Finerenone with high yield. It also relates to industrially viable process for the preparation of Finerenone (I).
ABSTRACT
“IMPROVED PROCESS FOR THE PREPARATION OF 5-(2-FLUOROPHENYL)-1H-PYRROLE-3-CARBALDEHYDE”
The present invention relates to an improved process for the preparation of 5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde (I) with high yield and purity.
ABSTRACT
“IMPROVED PROCESS FOR 2-((1R,4R)-4-((TERT-BUTOXYCARBONYL) AMINO) CYCLOHEXYL) ETHYL METHANE SULFONATE”
The present invention relates to an improved process for the preparation of 2-((1R,4R)-4-((tert-butoxycarbonyl) amino) cyclohexyl) ethyl methane sulfonate, which is used key intermediate for the pr...
ABSTRACT
“NOVEL SYNTHESIS OF 5-(2-FLUOROPHENYL)-1H-PYRROLE-3-CARBALDEHYDE”
The present invention relates to a process for the preparation of 5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde by using novel compound of formula (XIII) and (XIV).
ABSTRACT
TITLE: PRODUCTION CRYSTALLINE FORMS OF RIFAXIMIN
The present invention relates to an improved process for the preparation of mixed crystalline Rifaximin a and Rifaximin ß.
ABSTRACT
“IMPROVED PROCESSES FOR THE PREPARATION OF ROXADUSTAT”
The present invention relates to an improved process for the preparation of Roxadustat and also provided a process for preparation of pure crystalline Form A of Roxadustat.
ABSTRACT
“CRYSTALLINE FORM P OF ISAVUCONAZONIUM SULFATE”
The invention relates to a crystalline form P of Isavuconazonium Sulfate is characterized by an X-ray powder diffraction pattern having characteristic peaks at about 4.27, 7.26, 11.94 and 20.91 ± 0.2 degrees of two-theta. The invention also relates t...
ABSTRACT
“PREPARATION OF 3'-AMINO-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID”
The present invention relates to a process for the preparation of 3'-amino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid with high yield and purity.
ABSTRACT
“CRYSTALLINE FORM OF PHENYRAMIDOL HYDROCHLORIDE”
The present invention relates to a crystalline form of Phenyramidol hydrochloride. The present invention also relates to process for the preparation of crystalline form of Phenyramidol hydrochloride with high purity and yield.
ABSTRACT
TITLE: CRYSTALLINE FORM-OS OF ELTROMBOPAG FREE ACID.
The present invention relates to crystalline Form-OS of Eltrombopag free acid (I). The present invention also relates to a purification process for preparing crystalline Form-OS of Eltrombopag free acid (I).
ABSTRACT
“IMPROVED PROCESS FOR THE PREPARATION OF ELTROMBOPAG OLAMINE”
The present invention relates to an improved process for the preparation of Eltrombopag Olamine and also relates to a process for the purification of Eltrombopag free acid.
ABSTRACT
“IMPROVED PROCESSES FOR THE PREPARATION OF UPADACITINIB”
The present invention relates to an improved process for the preparation of Upadacitinib with high yield and purity.
ABSTRACT
“IMPROVED PROCESS FOR THE PREPARATION OF ELTROMBOPAG OLAMINE BY USING AMINE SALTS”
The present invention relates to an improved process for the preparation of Eltrombopag Olamine by using amine salts and also relates to a process for the purification of Eltrombopag amine salts.
ABSTRACT
“PREPARATION OF PYRIDINE-3-SULFONYL CHLORIDE”
The present invention relates to a process for the preparation of Pyridine-3-sulfonyl chloride with high yield and purity.
ABSTRACT
TITLE: PURIFICATION CRYSTALLINE FORM A OF VONOPRAZAN FUMARATE
The present invention relates to a purification crystalline form A of Vonoprazan Fumarate with high purity.
ABSTRACT
“IMPROVED PROCESSES FOR THE PREPARATION OF TAFAMIDIS”
The present invention relates to an improved process for the preparation of Tafamidis. And also the present invention relates to a simple, cost effective, commercially viable and industrially applicable process of Tafamidis with high yield
...
ABSTRACT
TITLE: “CRYSTALLINE FORM OF TRISODIUM SACUBITRIL VALSARTAN HYDRATE AND A PROCESS FOR PREPARATION THEREOF”
The present invention relates to a crystalline Form P of a trisodium Sacubitril valsartan hydrate. Particularly, present invention relates to a process for the preparation of crystalline Form P of...
“Solid Dispersion Of Trisodium Sacubitril Valsartan Complex And Process For The Preparation Thereof”
ABSTRACT
“SOLID DISPERSION OF TRISODIUM SACUBITRIL VALSARTAN COMPLEX AND PROCESS FOR THE PREPARATION THEREOF”
The present invention relates to an amorphous solid dispersion of trisodium Sacubitril valsartan complex with copovidone or colloidal silicon dioxide and process for preparation of amorphous solid dis...
ABSTRACT
“PREPARATION OF 1-[(BENZYLOXY)CARBONYL]-4-ETHYL-2,5-DIHYDRO-1H-PYRROLE-3-CARBOXYLIC ACID”
The present invention relates to a process for the preparation of 1-[(benzyloxy)carbonyl]-4-ethyl-2,5-dihydro-1H-pyrrole-3-carboxylic acid with high yield and purity.
ABSTRACT
“PROCESS FOR 5-(2-FLUORO-3-METHOXYPHENYL)-1-(2-FLUORO-6-(TRIFLUOROMETHYL) BENZYL)-6-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE”
The present invention relates to an improved process for the preparation of 5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methylpyrimidine-2,4(1h,3h) dione (...
ABSTRACT
“IMPROVED PROCESS FOR THE PREPARATION OF OZENOXACIN”
The present invention relates to an improved process for the preparation of Ozenoxacin and also relates to a process for the purification of Ozenoxacin.
“AN IMPROVED PROCESS FOR THE PREPARATION OF 5-(2-FLUOROPHENYL)-1H-PYRROLE-3-CARBALDEHYDE”
The present invention relates to an improved process for the preparation of 5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde by using novel compound of formula (XIIA), an intermediate in the synthesis of Vonoprazan Fumarate.
...
ABSTRACT
“CRYSTALLINE FORM I OF CENOBAMATE”
The present invention relates to crystalline Form I of Cenobamate. The present invention also relates to a process for the preparation of crystalline Form I of Cenobamate with high purity and yield.
TITLE: “SYNTHESIS OF 3'-AMINO-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID”
The present invention relates to a synthesis of 3'-amino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid (I).
ABSTRACT
TITLE: CRYSTALLINE FORM I OF ETHACIZINE HYDROCHLORIDE
The present invention relates to crystalline form I of Ethacizine hydrochloride. The present invention also relates to a purification process for preparing crystalline form I of Ethacizine hydrochloride.
“A PROCESS FOR THE PREPARATION OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE”
The present invention relates to a process for the preparation of 3-Ethylbicyclo[3.2.0]hept-3-en-6-one with high yield and purity, which is key intermediate for the preparation of Mirogabalin Besylate
ABSTRACT
“AN IMPROVED PROCESS FOR PREPARATION OF DAPAGLIFLOZIN
PROPANEDIOL MONOHYDRATE”
The present invention relates to an improved process for preparing Dapagliflozin propanediol monohydrate, represented by formula (I). The invention also relates to the preparation of a substantially pure tetra acetyl inte...
“AN IMPROVED PROCESS FOR THE PREPARATION OF LINAGLIPTIN”
The present invention relates to an improved process for the preparation of Linagliptin (I), comprising reacting the compound of formula (II) with compound of formula (III) in presence of base, solvent and phase transfer catalyst (PTC) to obtain compound o...
The present invention relates to improved methods for commercially preparing and separating compound 1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethanone (1a) from a reaction mixture containing compound 1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethanone (1a) and compound 1-(2-chlorophenyl)-2-(1H-tetrazol-2-yl)ethanone (1b),...
TITLE: IMPROVED PROCESS FOR THE PREPARATION OF PURE CRYSTALLINE FORM-I OF CRISABOROLE.
The present invention relates to improved process for the preparation of pure crystalline Form-I of Crisaborole having purity of greater than 99.8%.
NOVEL PROCESS FOR THE PREAPARATION OF AMOROLFINE HYDROCHLORIDE”
The present invention relates to a novel process for the preparation of Amorolfine hydrochloride (I). Furthermore, the invention pertains to novel compounds of formulae (IV) and (V), which are used in the preparation of Amorolfine hydrochloride (I) wit...
The present invention relates to a synthesis of butyl 1-bromo-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate and also provided a purification of butyl 1-bromo-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate.
TITLE: CRYSTALLINE FORM S1 OF TAPINAROF
The present invention provides a crystalline Form S1 of Tapinarof. The present invention also relates to a process for preparing crystalline Form S1 of Tapinarof.
“A PROCESS FOR THE PREPARATION OF (3R,4R)-1-BENZYL-N,4-DIMETHYL PIPERIDIN-3-AMINE DIHYDROCHLORIDE (VI)”
The present invention relates to a process for the preparation of (3R,4R)-1 Benzyl N,4 dimethylpiperidin 3 amine dihydrochloride (VI), a key intermediate in the synthesis of Tofacitinib citrate. The invention f...
AN IMPROVED PROCESS FOR THE PREPARATION OF LUMATEPERONE AND SALT THEREOF
The present invention relates to an improved process for the preparation of Lumateperone of Formula (I) and salt thereof with high yield and purity.
ABSTRACT
“AN IMPROVED PROCESS FOR THE PREAPARATION OF AMOROLFINE HYDROCHLORIDE”
The present invention relates to an improved process for the preparation of Amorolfine hydrochloride (I). Furthermore, the invention pertains to novel compounds of formulae (VIa), which is used in the preparation of Amorolfine hydrochl...
TITLE: AN IMPROVED PROCESS FOR THE PREPARATION OF TAPINAROF AND ITS INTERMEDIATES
The present invention relates to an improved process for the preparation of Tapinarof and a process for the preparation of Tapinarof intermediates.
Title: PROCESS FOR THE PREPARATION OF MIROGABALIN BESYLATE
The present invention relates a process for the preparation of Mirogabalin Besylate with high yield and purity.
ABSTRACT
“AN IMPROVED PROCESS FOR THE PREPARATION OF TEGOPRAZAN”
The present invention relates to an improved process for the preparation of Tegoprazan, which provides high yield and high purity. Furthermore, the present invention provides an economical and technically simple process for the preparation of Teg...
Registered Trademarks
[Class : 35] Whole Sale And Retail Trading Of Pharmaceuticals And Medical Preparations; Surgical , Medical And Dental Apparatus And Instruments.
[Class : 10] Surgical, Medical, Dental And Veterinary Apparatus And Instruments; Artificial Limbs, Eyes And Teeth; Orthopaedic Articles; Suture Materials; Therapeutic And Assistive Devices Adapted For The Disabled; Massage Apparatus; Apparatus Devices And Articles For Nursing Infants Sexual Activity Apparatus, Devices And Articles.
[Class : 5] Pharmaceuticals, Medical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies; Dietary Supplements For Humans And Animals; Plasters, Materials For Dressings; Material For Stopping Teeth, Dental Wax; Disinfectants; Preparations For Destroying Vermin; Fungicides ...
View +5 more Brands for Optimus Drugs Private Limited.
Charges
30 July 2018
Hdfc Bank Limited
33 Crore
16 September 2017
Hdfc Bank Limited
61 Crore
15 September 2017
Hdfc Bank Limited
40 Crore
25 June 2015
Icici Bank Limited
29 Crore
08 November 2013
Axis Bank Limited
25 Crore
30 October 2015
Reliance Capital Ltd
69 Lak
31 December 2014
Reliance Capital Ltd
1 Crore
12 October 2011
Standard Chartered Bank
11 Crore
15 July 2011
Standard Chartered Bank
11 Crore
24 November 2006
Small Industries Developement Bank Of India
6 Crore
15 November 2019
Kotak Mahindra Bank Limited
20 Crore
04 July 2019
Axis Bank Limited
14 Lak
11 November 2022
Axis Bank Limited
0
10 May 2022
Hdfc Bank Limited
0
15 November 2019
Others
0
31 July 2019
Others
0
23 October 2017
Hdfc Bank Limited
0
04 July 2019
Axis Bank Limited
0
15 September 2017
Hdfc Bank Limited
0
08 November 2013
Axis Bank Limited
0
30 July 2018
Hdfc Bank Limited
0
24 November 2006
Small Industries Developement Bank Of India
0
30 October 2015
Reliance Capital Ltd
0
16 September 2017
Hdfc Bank Limited
0
25 June 2015
Others
0
31 December 2014
Reliance Capital Ltd
0
15 July 2011
Standard Chartered Bank
0
12 October 2011
Standard Chartered Bank
0
11 November 2022
Axis Bank Limited
0
10 May 2022
Hdfc Bank Limited
0
15 November 2019
Others
0
31 July 2019
Others
0
23 October 2017
Hdfc Bank Limited
0
04 July 2019
Axis Bank Limited
0
15 September 2017
Hdfc Bank Limited
0
08 November 2013
Axis Bank Limited
0
30 July 2018
Hdfc Bank Limited
0
24 November 2006
Small Industries Developement Bank Of India
0
30 October 2015
Reliance Capital Ltd
0
16 September 2017
Hdfc Bank Limited
0
25 June 2015
Others
0
31 December 2014
Reliance Capital Ltd
0
15 July 2011
Standard Chartered Bank
0
12 October 2011
Standard Chartered Bank
0
11 November 2022
Axis Bank Limited
0
10 May 2022
Hdfc Bank Limited
0
15 November 2019
Others
0
31 July 2019
Others
0
23 October 2017
Hdfc Bank Limited
0
04 July 2019
Axis Bank Limited
0
15 September 2017
Hdfc Bank Limited
0
08 November 2013
Axis Bank Limited
0
30 July 2018
Hdfc Bank Limited
0
24 November 2006
Small Industries Developement Bank Of India
0
30 October 2015
Reliance Capital Ltd
0
16 September 2017
Hdfc Bank Limited
0
25 June 2015
Others
0
31 December 2014
Reliance Capital Ltd
0
15 July 2011
Standard Chartered Bank
0
12 October 2011
Standard Chartered Bank
0
Documents
Form MSME FORM I-04042021_signed
Form MSME FORM I-09012021_signed
Form MSME FORM I-30122020_signed
Form DPT-3-18122020_signed
Instrument(s) of creation or modification of charge;-07112020
Form CHG-1-07112020_signed
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20201107
Form BEN - 2-02102020_signed
Declaration under section 90-30092020
Form CHG-1-07092020_signed
Instrument(s) of creation or modification of charge;-07092020
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20200907
Form CHG-1-03092020_signed
Instrument(s) of creation or modification of charge;-03092020
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20200903
Instrument(s) of creation or modification of charge;-29072020
Form CHG-1-29072020_signed
Optional Attachment-(1)-29072020
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20200729
Form DPT-3-01072020-signed
Form CHG-1-17022020-signed
CERTIFICATE OF REGISTRATION OF CHARGE-20200217
Form CHG-1-25122019_signed
List of share holders, debenture holders;-24122019
Optional Attachment-(1)-24122019
Copy of MGT-8-24122019
Instrument(s) of creation or modification of charge;-24122019
CERTIFICATE OF REGISTRATION OF CHARGE-20191224
Form MGT-7-24122019
Form AOC-4(XBRL)-29112019_signed
